Bilimsel Makale Arama | NeuralCipher AI

Kaynak kaydı

MS-based methods for biomarkers of Parkinson's disease: what is the future?

Barkovits K, Helling S, Marcus K.

Bioanalysis · 2015-01-01

DOI: 10.4155/bio.14.273PMID: 25587831

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Kaynak kaydı

A current review for biological monitoring of manganese with exposure, susceptibility, and response biomarkers.

Kim G, Lee HS, Seok Bang J, Kim B, Ko D, Yang M.

J Environ Sci Health C Environ Carcinog Ecotoxicol Rev · 2015-01-01

DOI: 10.1080/10590501.2015.1030530PMID: 26023759

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Açık erişim

Myalgic Encephalomyelitis: Symptoms and Biomarkers.

Jason LA, Zinn ML, Zinn MA.

Curr Neuropharmacol · 2015-01-01

DOI: 10.2174/1570159x13666150928105725PMID: 26411464

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Kaynak kaydı

Peripheral Biomarkers of Parkinson's Disease Progression and Pioglitazone Effects.

Simon DK, Simuni T, Elm J, Clark-Matott J, Graebner AK, Baker L, Dunlop SR, Emborg M, Kamp C, Morgan JC, Ross GW, Sharma S, Ravina B, NINDS NET-PD Investigators.

J Parkinsons Dis · 2015-01-01

DOI: 10.3233/jpd-150666PMID: 26444095

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Kaynak kaydı

[Dopamine neurotransmission of peripheral blood lymphocytes is a potential biomarker of psychiatric and neurological disorders].

Taraskina AE, Nasyrova RF, Grunina MN, Zabotina AM, Ivashchenko DV, Ershov EE, Sosin DN, Kirnichnaya KA, Ivanov MV, Krupitsky EM.

Zh Nevrol Psikhiatr Im S S Korsakova · 2015-01-01

DOI: 10.17116/jnevro20151159165-69PMID: 26569007

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Kaynak kaydı

Associations between Cerebrospinal Fluid Biomarkers and Cognition in Early Untreated Parkinson's Disease.

Skogseth RE, Bronnick K, Pereira JB, Mollenhauer B, Weintraub D, Fladby T, Aarsland D.

J Parkinsons Dis · 2015-01-01

DOI: 10.3233/jpd-150682PMID: 26599300

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Kaynak kaydı

Pull Test estimation in Parkinson's disease patients using wearable sensor technology.

Pasluosta CF, Barth J, Gassner H, Klucken J, Eskofier BM.

Annu Int Conf IEEE Eng Med Biol Soc · 2015-01-01

DOI: 10.1109/embc.2015.7319050PMID: 26736950

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Kaynak kaydı

Comparisons of clinical symptoms in biomarker-confirmed Alzheimer's disease, dementia with Lewy bodies, and frontotemporal dementia patients in a local memory clinic.

Shea YF, Ha J, Chu LW.

Psychogeriatrics · 2014-12-23

DOI: 10.1111/psyg.12103PMID: 25533477

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Kaynak kaydı

Cerebrospinal fluid proteomics and protein biomarkers in frontotemporal lobar degeneration: Current status and future perspectives.

Oeckl P, Steinacker P, Feneberg E, Otto M.

Biochim Biophys Acta · 2014-12-17

DOI: 10.1016/j.bbapap.2014.12.010PMID: 25526887

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Kaynak kaydı

Cerebrospinal fluid biomarkers in trials for Alzheimer and Parkinson diseases.

Lleó A, Cavedo E, Parnetti L, Vanderstichele H, Herukka SK, Andreasen N, Ghidoni R, Lewczuk P, Jeromin A, Winblad B, Tsolaki M, Mroczko B, Visser PJ, Santana I, Svenningsson P, Blennow K, Aarsland D, Molinuevo JL, Zetterberg H, Mollenhauer B.

Nat Rev Neurol · 2014-12-16

DOI: 10.1038/nrneurol.2014.232PMID: 25511894

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Açık erişim

What is the Clinical Significance of Cerebrospinal Fluid Biomarkers in Parkinson's disease? Is the Significance Diagnostic or Prognostic?

Kim D, Paik JH, Shin DW, Kim HS, Park CS, Kang JH.

Exp Neurobiol · 2014-12-12

DOI: 10.5607/en.2014.23.4.352PMID: 25548535

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Açık erişim

Saliva α-Synuclein and A High Extinction Coefficient Protein: A Novel Approach in Assessment Biomarkers of Parkinson's Disease.

Al-Nimer MS, Mshatat SF, Abdulla HI.

N Am J Med Sci · 2014-12-01

DOI: 10.4103/1947-2714.147980PMID: 25599051

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Kayıtlar bilimsel kaynaklardan alınır. Bibliyografik kayıt sayısı, Türkçe çeviri veya editoryal onay sayısı değildir.

2.742 makale bulundu

MS-based methods for biomarkers of Parkinson's disease: what is the future?

A current review for biological monitoring of manganese with exposure, susceptibility, and response biomarkers.

Myalgic Encephalomyelitis: Symptoms and Biomarkers.

Peripheral Biomarkers of Parkinson's Disease Progression and Pioglitazone Effects.

[Dopamine neurotransmission of peripheral blood lymphocytes is a potential biomarker of psychiatric and neurological disorders].

Associations between Cerebrospinal Fluid Biomarkers and Cognition in Early Untreated Parkinson's Disease.

Pull Test estimation in Parkinson's disease patients using wearable sensor technology.

Comparisons of clinical symptoms in biomarker-confirmed Alzheimer's disease, dementia with Lewy bodies, and frontotemporal dementia patients in a local memory clinic.

Cerebrospinal fluid proteomics and protein biomarkers in frontotemporal lobar degeneration: Current status and future perspectives.

Cerebrospinal fluid biomarkers in trials for Alzheimer and Parkinson diseases.

What is the Clinical Significance of Cerebrospinal Fluid Biomarkers in Parkinson's disease? Is the Significance Diagnostic or Prognostic?

Saliva α-Synuclein and A High Extinction Coefficient Protein: A Novel Approach in Assessment Biomarkers of Parkinson's Disease.

Filtreler